GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lisata Therapeutics Inc (FRA:8NE) » Definitions » Shiller PE Ratio

Lisata Therapeutics (FRA:8NE) Shiller PE Ratio : (As of Jun. 11, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Lisata Therapeutics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Lisata Therapeutics Shiller PE Ratio Historical Data

The historical data trend for Lisata Therapeutics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lisata Therapeutics Shiller PE Ratio Chart

Lisata Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Lisata Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lisata Therapeutics's Shiller PE Ratio

For the Biotechnology subindustry, Lisata Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lisata Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lisata Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Lisata Therapeutics's Shiller PE Ratio falls into.



Lisata Therapeutics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Lisata Therapeutics's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Lisata Therapeutics's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.598/131.7762*131.7762
=-0.598

Current CPI (Mar. 2024) = 131.7762.

Lisata Therapeutics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -44.160 100.560 -57.869
201409 -55.872 100.428 -73.312
201412 -37.711 99.070 -50.161
201503 -70.686 99.621 -93.502
201506 -51.322 100.684 -67.171
201509 -27.532 100.392 -36.139
201512 -86.338 99.792 -114.010
201603 -28.152 100.470 -36.924
201606 -17.756 101.688 -23.010
201609 -14.568 101.861 -18.846
201612 -7.679 101.863 -9.934
201703 -15.708 102.862 -20.123
201706 57.939 103.349 73.876
201709 -4.782 104.136 -6.051
201712 -4.816 104.011 -6.102
201803 -6.326 105.290 -7.917
201806 -5.393 106.317 -6.684
201809 -4.628 106.507 -5.726
201812 -4.747 105.998 -5.901
201903 -5.841 107.251 -7.177
201906 -6.505 108.070 -7.932
201909 -6.401 108.329 -7.786
201912 -6.480 108.420 -7.876
202003 -5.158 108.902 -6.241
202006 6.660 108.767 8.069
202009 -3.693 109.815 -4.432
202012 -4.192 109.897 -5.027
202103 -2.394 111.754 -2.823
202106 -1.245 114.631 -1.431
202109 -1.479 115.734 -1.684
202112 -1.496 117.630 -1.676
202203 -0.953 121.301 -1.035
202206 -1.551 125.017 -1.635
202209 -7.959 125.227 -8.375
202212 -0.716 125.222 -0.753
202303 -0.719 127.348 -0.744
202306 -0.462 128.729 -0.473
202309 -0.609 129.860 -0.618
202312 -0.605 129.419 -0.616
202403 -0.598 131.776 -0.598

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Lisata Therapeutics  (FRA:8NE) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Lisata Therapeutics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Lisata Therapeutics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lisata Therapeutics (FRA:8NE) Business Description

Traded in Other Exchanges
Address
110 Allen Road, 2nd Floor, Basking Ridge, NJ, USA, 07920
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases.

Lisata Therapeutics (FRA:8NE) Headlines

No Headlines